Skip to Main Content

Paper Details

Extreme Responses to a Combination of DNA-Damaging Therapy and Immunotherapy in CDK12-Altered Metastatic Castration-Resistant Prostate Cancer: A Potential Therapeutic Vulnerability.
Clin Genitourin Cancer
2
2022
Author NameAffiliation
Pedro Isaacsson VelhoJohns Hopkins School of Medicine, Hospital Moinhos de Vento
Anamaria A CamargoMolecular Oncology Center, Hospital Sirio-Libanes
Emmanuel S AntonarakisUniversity of Minnesota
  • 1 - 3

Datasets

Release 1.2